EcoDrugPlus

Granzyme B-Like

Ensembl ID : ENSFHEG00000007332
Gene Symbol: LOC105923873
2 Cross references
1041 Possible Orthologues:

Granzyme E-Like

Ensembl ID : ENSFHEG00000021505
Gene Symbol: LOC105932439
2 Cross references
1073 Possible Orthologues:

Group 10 Secretory Phospholipase A2

Ensembl ID : ENSFHEG00000020367
Gene Symbol: LOC105922122
3 Cross references
233 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSFHEG00000022852
Gene Symbol: GHRHR
3 Cross references
193 Possible Orthologues:

Growth Hormone Secretagogue Receptor Type 1-Like

Ensembl ID : ENSFHEG00000018039
Gene Symbol: LOC105935364
3 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSFHEG00000021895
Gene Symbol: GUCY1A1
3 Cross references
201 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSFHEG00000003659
Gene Symbol: GUCY1A2
4 Cross references
204 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSFHEG00000021832
Gene Symbol: GUCY1B1
3 Cross references
211 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class B Member 1

Ensembl ID : ENSFHEG00000003450
Gene Symbol: HSP90AB1
3 Cross references
355 Possible Orthologues:

Heat Shock Protein Hsp 90-Alpha

Ensembl ID : ENSFHEG00000018363
Gene Symbol: LOC105919227
3 Cross references
317 Possible Orthologues:

High Mobility Group Protein B1-Like

Ensembl ID : ENSFHEG00000011928
Gene Symbol: LOC105917618
3 Cross references
512 Possible Orthologues:

High Mobility Group-T Protein

Ensembl ID : ENSFHEG00000001216
Gene Symbol: LOC105937381
2 Cross references
498 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).